Jasminka Sincic-Petricevic - Clin Internal Med, Univ Hosp Ctr Osijek

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 13 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P-382 Ixazomib in Relapsed/Refractory Multiple Myeloma Patients – Real World Evidence – Experiences of the Croatian Cooperative Group for Hematologic Diseases (Krohem)

Josip Batinic,Barbara Dreta,Rincic Goran, Antonia Mrdeza,Karla Misura Jakobac,Delfa Radic-Kristo,Milan Vujcic,Mario Pirsic,Zeljko Jonic,Vlatka Perisa,Jasminka Sincic-Petricevic,Bozena Coha,Hrvoje Holik,Toni Valkovic, Marija Stanic, Ivan Krecak, Ante Stojanovic, Domagoj Sajfert,Sandra Basic-Kinda,Igor Aurer

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S253-S254

引用0浏览0引用

P-258 Carfilzomib in Relapsed/refractory Multiple Myeloma Patients – Real World Evidence: Experiences of the Croatian Cooperative Group for Hematologic Diseases (KROHEM)

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2023): S178-S178

引用0浏览0引用

Efficacy and toxicity of ibrutinib in CLL Croatian experience. A non-interventional, real world study of KroHem

Igor Aurer, Nikola Bulj,Barbara Dreta, Inga Mandac-Smoljanovic, Antonija Miljak,Fran Petricevic,Marija Ivic,Sandra Basic-Kinda, Viktor Zatezalo, Martina Madunic,Dubravka Carzavec,Jasminka Sincic-Petricevic,Dragana Grohovac,Ozren Jaksic,Ivan Krecak,Martina Moric-Peric,Bozena Coha,Petra Bernes, Neno Zivkovic,Vlatko Pejsa

LEUKEMIA & LYMPHOMA (2023): S87-S88

引用0浏览0引用

P-234 Daratumumab in Relapsed/refractory Multiple Myeloma Patients – Real World Evidence – Experiences of the Croatian Cooperative Group for Hematologic Diseases (KROHEM)

Josip Batinic,Barbara Dreta,Davor Galusic,Milan Vujcic,Marin Simunic,Delfa Radic Kristo,Karla Misura Jakobac,Mario Pirsic,Anica Sabljic,Goran Rincic,Klara Brcic,Fran Petricevic,Jasminka Sincic-Petricevic,Vlatka Perisa,Toni Valkovic, Tajana Grenko,Hrvoje Holik,Martina Moric Peric,Ivan Zekanovic,Ivan Krecak,Petra Bernes,Luka Kuzat, Ranata Babok Flegaric, Elizabeta Corovic-Arneri,Sandra Basic-Kinda

Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia (2023): S164-S164

引用0浏览0引用

Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases

Davor Galusic,Sandra Basic-Kinda,Andela Pijuk,Vibor Milunovic,Barbara Dreta,Neven Franjic,Bozena Coha,Jasminka Sincic-Petricevic,Petar Gacina,Vlatko Pejsa,Marko Lucijanic,Igor Aurer

HemaSphere（2022）

引用1浏览0WOS引用

Tetraploid Acute Promyelocytic Leukemia with Double Translocation T (15,17) PML/RARA: the First Case Report in Croatia and Europe

Vlatka Perisa,Dorian Laslo,Ivana Franic-Simic,Jasminka Sincic-Petricevic

IRDR（2021）

引用0浏览0WOS引用

Improvement in the Outcomes of Mantle Cell Lymphoma in the Last Decade: a Real-Life Non Interventional Study of the Croatian Cooperative Group for Hematologic Diseases

Sandra Basic-Kinda,Karla Misura Jakobac,Jasminka Sincic-Petricevic, Dajana Deak,Marijo Vodanovic,Marinka Jakic-Bubalo, Zdravko Mitrovic,Aron Grubesic,Barbara Dreta,Dubravka Zupanic Krmek,Bozena Coha,Delfa Radic-Kristo,Igor Aurer

Croatian Medical Journal（2021）

引用2浏览0WOS引用

Feasibility of obinutuzumab (G) combined with higher doses of chlorambucil (Clb) for frontline treatment of CLL: a retrospective non-interventional study of KroHem, the Croatian Cooperative Group for Hematologic Diseases

Igor Aurer,Ozren Jaksic,Sandra Basic-Kinda,Karla Misura Jakobac,Jasminka Sincic-Petricevic,Sabina Novakovic Coha,Davor Galusic,Hrvoje Holik,Toni Valkovic, Dubravka Zupanic-Krmek, Ida Hude Dragicevic,Vibor Milunovic,Vlatko Pejsa

LEUKEMIA & LYMPHOMA（2020）

引用0浏览0引用

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA. KROHEM B-CLL 2017

Branimir Jaksic,Vlatko Pejsa,Slobodanka Ostojic-Kolonic,Ika Kardum-Skelin,Sandra Basic-Kinda,Bozena Coha,Velka Gveric-Krecak,Radovan Vrhovac,Ozren Jaksic,Igor Aurer,Jasminka Sincic-Petricevic,Antica Nacinovic-Duletic,Damir Nemet

Acta clinica Croatica（2018）

引用6浏览0WOS引用

Quantitative assessment of leukemia burden, response and redistribution during ibrutinib monotherapy in B-CLL by total tumor mass score (TTM) and CT volumetry - KROHEM CLL2 study

Ozren Jaksic, Renata Huzjan,Sandra Basic-Kinda,Dubravka Carzavec,Vlatko Pejsa,Damir Nemet,Slobodanka Ostojic-Kolonic,Kresimir Grgat,Igor Aurer,Branimir Jaksic, Stipe Rados,Goran Rincic,Visnja Haris,Jasminka Sincic-Petricevic, Inga Mandac Rogulj

LEUKEMIA & LYMPHOMA（2017）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn